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Abstract
Mitochondrial electron transport chain (ETC) defects are observed in Parkinson’s disease (PD) patients and in PD fly- and
mouse-models; however it remains to be tested if acute improvement of ETC function alleviates PD-relevant defects. We
tested the hypothesis that 808 nm infrared light that effectively penetrates tissues rescues pink1 mutants. We show that
irradiating isolated fly or mouse mitochondria with 808 nm light that is absorbed by ETC-Complex IV acutely improves
Complex IV-dependent oxygen consumption and ATP production, a feature that is wavelength-specific. Irradiating
Drosophila pink1 mutants using a single dose of 808 nm light results in a rescue of major systemic and mitochondrial
defects. Time-course experiments indicate mitochondrial membrane potential defects are rescued prior to mitochondrial
morphological defects, also in dopaminergic neurons, suggesting mitochondrial functional defects precede mitochondrial
swelling. Thus, our data indicate that improvement of mitochondrial function using infrared light stimulation is a viable
strategy to alleviate pink1-related defects.
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Introduction
Parkinson’s disease (PD) is a common neurological disease and
patients are characterized by progressive dysfunction of the
dopaminergic system, explaining motor symptoms [1]. Current
therapeutic strategies are mostly focused on managing the
symptoms via restoration of dopaminergic tonus using pharmaco-
logical agents or via deep brain stimulation [2]. However, the
beneficial effects of these strategies are limited in time and
significant side-effects have been reported [2–4]. Hence, new
methodologies that prevent or delay neuronal dysfunction in PD
are eagerly awaited.
Environmental factors as well as loss-of-function of several PD-
related genes in flies and mice indicate that mitochondrial defects
might be a rather common problem in the disease process [5–11].
Hence, alleviating mitochondrial defects may be a promising
strategy for those PD patients that suffer from mitochondrial
deficits. Pink1 is a mitochondrial serine/threonine kinase mutated
in PD and loss of Pink1 in different species results in mitochondrial
failure [5,7,12,13]. Pink1 mutant fruit flies show, along with
locomotion defects, disrupted mitochondrial membrane potential,
reduced ATP levels, reduced Complex I activity and abnormal
mitochondrial morphology and swelling [7,12,13]. Based on
molecular studies and genetic interactions, Pink1 has been
suggested to act at different levels; the protein is thought to
regulate mitochondrial quality control and autophagy together
with Parkin [14–18], and it has also been implicated in the control
of mitochondrial function by regulating the electron transport
chain [5,7,11,19]. However, the relative contribution of these
pathways to Pink1–related pathology remains unclear [11,20–22]
nor is it known whether acutely improving ETC function is a
valuable therapeutic approach for PD patients that suffer from
Pink1-induced mitochondrial dysfunction.
The application of long wavelength light (referred to as
photobiomodulation or PBM) is thought to exert beneficial effects
in wound healing, stroke, optic axonal degeneration and ischemic
heart injury [23–25]. Furthermore, PBM has also been shown to
exert a protective effect on cells [26] and it was shown to protect
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dopaminergic neurons to MPTP-induced toxicity in rodents [27].
However, the mechanism by which PBM exerts these beneficial
effects has remained largely elusive, although an effect on
mitochondrial function has been suggested [28]. Given that
Parkinson disease fly models display mitochondrial disfunction, we
tested the hypothesis that long wavelength 808 nm monochro-
matic light that is absorbed by Complex IV in cells [28], improves
ETC function and can rescue mitochondrial and organismal
defects in adult Drosophila pink1 mutants. While infra-red light
effectively penetrates flies, such a strategy may harbor therapeutic
potential in patients as well, provided it is combined with an
implantable device to locally deliver the light.
Materials and Methods
All animal experiments were conducted with the approval of the
KU Leuven ethics committee.
Flies and Irradiation
Animals were grown on standard cornmeal and molasses
medium. Pink1 null mutants were w pink1B9 and controls were w
pink1RV. park null mutants were w park1/D21 and controls were
parkRV. Pink1B9, pink1RV, park1 and parkRV controls were from Jeehye
Park and Jongkyeong Chung (KAIST) (Park et al, 2006), parkD21
mutant flies were a gift from Graeme Mardon (BCM) (Pesah et al,
2004). Drp1 mutants were y w eyFlp GMR::LacZ; p(y+) drp11/2
FRT40A from Hugo Bellen (BCM) and controls were y w eyFlp
GMR::LacZ; p(y+) FRT40A. Mutant animals were selected by the
absence of the GFP-marked balancers.
For illumination, animals were placed in a 24-well plate
(Thermo Scientific BioLite, Langenselbold, Germany), and
covered with the plate lid. The plates were bottom-illuminated
using continuous lasers that were coupled to a frontal light
distributor to homogenize the illumination spot (FD1, Medlight
SA, Ecublens, Switzerland). The output power was measured at
the distal tip of the light distributor with the help of a powermeter
(1918-R, Newport, Darmstadt, Germany), equipped with a
thermopile sensor (818P-010-12, Newport, Darmstadt, Germany).
Experiments were performed with an 808 nm-GaAs laser diode
(RLTMDL-808-2W with a PSU-LED power supply, Roithner
Lasertechnik GmbH, Vienna, Austria) or with a 730 nm laser
diode (LTL730S with a ADR-1805 driver, Leading-Tech Laser
Co. LTD, Shanghai, China). For the 808 nm laser, we tested
different illumination irradiances (10–25 mW/cm2), illumination
durations (25–200 s) and delays between illumination and
observation (15 min –24 h) but found that an irradiance of
25 mW/cm2 during 100 s, which corresponds to a light dose of
2.5 J/cm2, and an incubation period of 5 h post-illumination (for
flight) to be most optimal. Mock illumination (control) was realized
by masking the external wells from light illumination, providing a
control population on the same 24-well plate (Figure 1).
Illumination of animals at different wavelengths was realized
with a Mai Tai HP with integrated Spectra-Physics 14 W
MillenniaH pump laser (Newport/SpectraPhysics, Darmstadt,
Germany). The tunable wavelengths range from 690 nm to
1040 nm and we used 690, 730, 755, 780, 808, 830, 865 and
900 nm of wavelength. The wavelength range was extended with
two laser diodes at 635 nm (Ceralas PDT 635/4W/3 nm/
400 um, Ceramoptec GmbH, Bonn, Germany), and 652 nm
(Ceralas PDT 652/4W/+24/400 um, Ceramoptec GmbH,
Bonn, Germany).
For rotenone treatment, first instar larvae were grown on
250 mM rotenone until the third instar stage as described [19].
Flight assays were conducted using male flies in batches of 5 flies
each. Flies were placed in an empty vial (5610 cm), gently tapped
and scored visually. Flies able to fly were given a score of 1 while
those that did not were given a score of 0 [19].
ATP
ATP levels in adult thoraces or heads was determined as
described [13] using an ATP determination kit (Invitrogen, Ghent,
Belgium). Luminescence was measured using a luminometer
(Biorad, Nazareth Eke, Belgium). The values were normalized to
total protein content (Bradford method). To determine ATP
production capacity in vitro, we first irradiated flies, waited 5 h
and then prepared mitochondrial fractions as described [29]. We
incubated 0.25 mg (Bradford method) mitochondrial fraction with
malate (1.25 mM), pyruvate (1.25 mM) and ADP (1.25 mM). We
first measured ATP levels in the mitochondrial fractions (t0) as
described above and waited for 15 or for 30 min and measured
ATP levels again in each of the fractions as to assess ATP
production capacity within this 15 or 30 min timeframe. The data
were normalized to ‘‘t0’’.
JC-1
For JC-1 (Molecular probes, Ghent, Belgium) labeling, larval
fillets were incubated for 1.5 min with 4 mM JC-1 in HL-3,
washed in HL-3 and red and green fluorescence in boutonic
mitochondria imaged [7]. Mitochondria in boutons were dis-
cerned from others by morphology: the green JC-1 labeling marks
bouton outlines. Images of neuromuscular boutons were captured
on a Nikon FN-1 microscope with a Clara Andor digital camera,
60x NA 1.0W objective and red over green intensity in the red
labeled areas within boutons was quantified using NIS-Elements
BR 3.1.
Immunohistochemistry and Quantification
For immunolabeling, larval fillets were fixed for 20 min in 4%
formaldehyde in PBS and permeabilized with 0.4% tritonX100.
Brain dissection and whole-mount immunohistochemistry for
tyrosine hydroxylase (TH) was performed as described (Wu and
Luo, 2006). Primary antibodies used: anti-ATP synthase subunit
beta mAb (1:100; MitoSciences, Cambridge, United Kingdom)
and Rabbit anti-TH (1:100; Chemicon, Darmstadt, Germany).
Secondary antibodies: goat anti-mouse alexa 488 and goat anti-
rabbit alexa 555 (Invitrogen, Ghent, Belgium). Images were
captured with a Zeiss LSM510META confocal microscope and a
63x NA 1.4 oil lens. For larval muscles, images of nuclear regions
in muscles 6 and 7 were taken. For TH positive cells in the adult
brain, cell bodies in cluster PPM3 were captured (but the
phenotypes of mitochondrial morphology were consistent across
DA clusters). For quantification of mitochondrial morphology in
larval muscles and dopaminergic neurons, the ‘analyzing particle’
plugin of ImageJ was used and rounded mitochondria were
automatically detected and their number quantified.
Oxygen Consumption Measurements
Oxygen consumption was measured with a Clark type oxygen
electrode fitted onto an oxygraph (hansatech) apparatus to follow
oxygen concentration over time [7]. Mitochondria were isolated
from flies [29] and mouse liver [7] as described previously. 10 mg
mitochondrial fraction were incubated in EB adapted (200 mM
sucrose, 2 mM KH2PO4 2 mM MgCl2, 10 mM MOPS and
0.1 mM EGTA/Tris) and ADP (300 mM). Complex-specific
substrates were added: glutamate (5 mM) and malate (2.5 mM)
for Complex I, succinate (5 mM) for Complex II and Ascorbate
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(6 mM) and TMPD (300 mM) for Complex IV. To inhibit
upstream Complexes rotenone (2 mM) was added for Complex II-
driven oxygen consumption measurements, antimycin A
(0.25 mg/ml) for Complex IV-driven oxygen consumption and
potassium cyanide (KCN 3 mM) to block Complex IV. To test if
laser light can stimulate oxygen consumption, we applied 808 nm
laser light of 25 mW/cm2 for 100 s directly onto the mitochon-
drial suspension and measured the slope of ADP-stimulated
oxygen consumption before and after the light stimulus. We
calculated the ratio of oxygen consumption after versus before
light stimulus. As a control we performed the same treatment but
did not switch on the light and calculated the ratio of the slope
after versus before ‘mock treatment’.
Figure 1. 808 nm light stimulation rescues pink1B9 flight defects. A- Experimental set-up used to illuminate groups of flies using the
described laser diodes (see Materials and Methods). ‘red’ wells are illuminated (light stimulation), ‘black’ wells are not (control). B–E Flight ability of 5-
day old pink1B9 mutants (B, D) and controls (C, E) illuminated with 808 nm (B–C) or 730 nm (D–E) (grey bars) (100 s at 25 mW/cm2) and not-
illuminated (black bars) tested at the times indicated after illumination. n = 10 times 5 flies per condition; data represent percentages6 SEM. ANOVA/
Dunnet: **: p,0.01; ***: p,0.001; ns = not significant.
doi:10.1371/journal.pone.0078562.g001
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Statistical Analysis
All experiments were evaluated using the appropriate ANOVA
test followed by post hoc Dunnett test using GraphPad Prism 6.
Results
808 nm Light Stimulation Rescues pink1 Mutant Flight
Defects
Complex IV of the ETC shows absorption maxima around
670 nm and 800–840 nm (see also below) [28], but the higher
wavelength penetrates tissues more effectively [30]. We used an
808 nm laser fitted with a frontal light distributor to simulta-
neously irradiate groups of control (pink1RV) and pink1B9 null
mutant animals (Figure 1A) using different conditions and tested
for their ability to fly at different time points following light
exposure (Figure 1B–C and Table S1). We find that pink1B9
mutant flies irradiated for 100 s with 25 mW/cm2 808 nm light
show rescue of their ability to fly which is most pronounced 5 h
following the light stimulation, while no effect was observed in
control flies (Figure 1B–C and Table S1). The rescue is only partial
but is very similar to the level obtained previously when testing
various genetic and pharmacological conditions suppressing pink1
mutant flight defects [11,13,19,20,31]. The rescue appears specific
to 808 nm light because irradiating pink1B9 mutants using 100 s of
25 mW/cm2 730 nm light that is less absorbed by Complex IV in
cells in vitro [32], does not rescue the inability of the mutants to fly
and has no effect on control flies (Figure 1D–E). In most of the
following experiments we thus used 100 s of 25 mW/cm2 808 nm
light to irradiate the flies.
808 nm Light Rescues Functional Defects in pink1
Mutant Mitochondria
Pink1B9 mutant flies suffer from mitochondrial dysfunction,
including lower ATP levels and reduced mitochondrial membrane
potential (ym) [7,12,13]. We irradiated adult mutant and control
flies and measured ATP levels 5 h later in neuron-enriched (heads)
and muscle-enriched (thoraces) material using a luciferase based
assay. Irradiation results in increased ATP levels (Figures 2A–B).
Similarly, we assessed ym at larval motor neuron endplates 5 h
after irradiation using JC-1, a potentiometric dye [33]. JC-1
reports on the ym at Drosophila motor endplates because in control
boutons, red JC-1 fluorescence is clearly visible while in samples
treated with the Complex I inhibitor rotenone, red labeling is
significantly reduced [19]. Similarly, in samples treated with
FCCP, an uncoupler, red labeling is lost [7]. As reported before,
red JC-1 fluorescence in pink1B9 larvae is reduced compared to
controls (pink1RV). While JC-1 red/green fluorescence ratio
between irradiated and non-irradiated pink1RV larvae is not
appreciably different (Figures 2C–D), red JC-1 fluorescence in
irradiated pink1B9 larvae is significantly rescued compared to non-
irradiated pink1B9 animals (Figures 2C–D). These data suggest that
808 nm light improves the mitochondrial membrane potential and
ATP levels in pink1B9 mutants.
808 nm Light Restores Mitochondrial Morphology and
this Rescue is Preceded by Functional Rescue
A hallmark phenotype in pink1 null mutant flies is the
accumulation of enlarged swollen mitochondria in some cell types
including muscle cells (Figures 3A–B) and dopaminergic neuron
cell bodies in adult flies (Figures 3C–D) [12,13]. Light stimulation
significantly decreases the number of aggregated and swollen
mitochondria (Figures 3A–D), but has no detectable effect on
mitochondrial morphology of control animals (Figures 3A–D).
Pink1 might act at different levels causing mitochondrial failure.
The protein regulates mitochondrial remodeling and autophagy in
a pathway with Parkin [17,34] and involving remodeling proteins
such as Drp1 [31,35,36]. On the other hand, Pink1 is also
implicated in the control of the ETC [5,7,11,19]. We tested if
PBM with 808 nm light impinges on these different mitochondrial
pathways. Wild type larvae intoxicated with rotenone, a Complex
I inhibitor, show reduced red JC-1 fluorescence [19]. Irradiating
these animals with 808 nm light results in a significant improve-
ment of the ym measured 5 h post irradiation (Figures S1A–B).
Remarkably, mitochondrial defects induced by loss of Parkin or
DRP1 are not rescued by 808 nm light (Figures S1C–I). Thus, the
data suggest that 808 nm light treatment improves mitochondrial
defects induced by pharmacological inhibition of the ETC but not
the mitochondrial defects induced by parkin or drp1 loss-of-
function mutations. These data may also suggest that the
improvement of mitochondrial function and morphology in pink1
mutants following light stimulation are to some extend caused by
effects on ETC performance. We therefore performed a time-
course experiment and assessed mitochondrial membrane poten-
tial and mitochondrial morphology at different time points
following light exposure. Fifteen minutes following irradiation,
pink1B9 mutant animals show already a significant rescue of the JC-
1 labeling defect that gradually decreases again in subsequent
hours (Figure 3E). In contrast, maximum rescue of mitochondrial
morphological defects occurs only 2 h after irradiation (Figure 3E).
The effect on morphology gradually disappears over a 24 h
period. Hence, these data indicate that maximal rescue of pink1B9
defects in mitochondrial function following light stimulation
precede, at least in part, the maximal rescue of morphological
defects in pink1B9 mutant mitochondria.
808 nm Light Facilitates Complex IV-dependent
Respiration
Given that Complex IV of the ETC absorbs 808 nm light in a
cellular context [28], we hypothesized that Complex IV may be an
important photo-acceptor through which mitochondrial function
is improved upon 808 nm PBM. We therefore measured, in real-
time, before and after irradiation, oxygen consumption of isolated
mitochondria that are energized with Complex-specific substrates,
while pharmacologically blocking the immediately upstream
complex. Ie, when energizing Complex II, we used rotenone to
inhibit Complex I, etc. We first measured Complex I-driven
oxygen consumption as basal rate versus ADP stimulated rate.
This is reduced in pink1B9 mutants compared to controls, as is
consistent with previous data [7]. We then measured the ratio of
the ADP-stimulated rate of oxygen consumption after light
treatment versus before light treatment. We also performed ‘mock
treatments’ where samples were handled identically but the light
was not turned on. If light stimulation activates Complex IV, and
Complex IV is in part limiting in the ETC, we expect ADP-
stimulated oxygen consumption of mitochondria energized with
substrates for one of the upstream complexes to be increased as
well, since for these measurements electrons are always transferred
to reduce oxygen in Complex IV. We find that ADP stimulated
Complex IV-driven oxygen consumption following light stimula-
tion is significantly increased in pink1B9 mutant mitochondria and
in pink1RV control mitochondria. Similarly, ADP stimulated
oxygen consumption of mitochondria energized with substrates
for the upstream ETC complexes is also significantly increased in
pink1B9 mutant mitochondria and in pink1RV control mitochondria
following light stimulation (Figures 4A–E). Likewise, mouse
mitochondria energized with different ETC substrates also show
a significant increase in the oxygen consumption after light
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stimulation (Figures 4F–J). While light stimulation boosts mito-
chondrial oxygen consumption in the presence of inhibitors of
Complex I or III (rotenone or antimycin; Figures 4B, G and 4C–
E, H–J respectively), we do not observe an increase in the oxygen
consumption rate following light stimulation in the presence of
potassium cyanide, a Complex IV inhibitor (Figure S2A). These
data indicate that 808 nm light has an acute effect on ETC
Complex IV-driven oxygen consumption. In line with these data,
we also find that ATP production of isolated pink1B9 mutant
mitochondria is significantly increased if animals are irradiated
with 808 nm light (Figure S2B). Hence, 808 nm light boosts
Complex IV-dependent mitochondrial oxygen consumption and
ATP production capacity.
In a cellular context, Complex IV shows two absorption
maxima (around 670 nm and 800–840 nm) in the infra-red light
range [28]. To further test if the light-induced rescue of pink1
mutant phenotypes correlates with this absorption spectrum, we
employed a tunable laser set-up to irradiate animals for 100 s with
25 mW/cm2 light at wavelengths between 635 nm and 900 nm
and assessed JC-1 labeling intensity at NMJ boutons. We find that
the reduced red JC-1 labeling in pink1 mutants is significantly
rescued when animals were illuminated with light of wavelengths
that are efficiently absorbed by Complex IV, but not when animals
were illuminated by light of other wavelengths (Figure S2C), while
in control (pink1RV) flies no difference between different wave-
lengths is observed. Taken together, these data are consistent with
the idea that infra-red light boosts Complex IV dependent
respiration and this feature can be used to significantly alleviate
the defects in a Pink1 PD model.
Discussion
In this work we show that PBM using 808 nm light is a strategy
that can be followed to alleviate symptoms associated with specific
forms of Parkinson’s disease. Our data using genetic models of
Parkinson’s disease that affect mitochondrial integrity are also
Figure 2. Functional defects in pink1B9 mutant mitochondria are rescued by 808 nm light. A–B- ATP concentration measured in thoracic
(A) and head (B) extracts from pink1RV control and pink1B9 null mutants 5 h after the flies were illuminated (808 nm light stimulation for 100 s at
25 mW/cm2; grey bars) or not illuminated (control; black bars) (n = 10 independent assays per condition). C–D- Images (D) and quantification (C) of
JC-1 labeling intensity (ratio of red/green fluorescence) as a measure of ym measured at NMJ synaptic bouton mitochondria of pink1RV control and
pink1B9 null mutant third instar larvae 5 h after flies were illuminated (grey bars) or not illuminated (black bars) (n = 20 synapses per condition). Data
in (A–C) are normalized to pink1RV without illumination 6 SEM. ANOVA/Dunnet: *: p,0.05; **: p,0.01.
doi:10.1371/journal.pone.0078562.g002
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Figure 3. Mitochondrial morphological defects in pink1B9 mutant muscles and DA neurons are rescued by 808 nm light. A–D- Images
(A, C) and quantification (B, D) of mitochondrial immunolabeling with Complex V (anti-ATP synthase b) antibody of pink1RV and pink1B9 mutant
muscles (muscles 6/7 in third instar larva) (A, B) and DA neuron cell bodies (PPM3 cluster in adult heads) marked by anti-TH labeling (C, D) 5 h after
flies were illuminated (808 nm, 100 s, 25 mW/cm2) or not illuminated (control). Quantification of the number of rounded/clumped mitochondria in
each condition, normalized to pink1RV without illumination (B, D). E- Time course of ym assessed as the ratio of red/green JC-1 fluorescence labeling
intensity measured at mitochondria in boutons of third instar larvae (green) as well as mitochondrial morphology assessed as the density of rounded
mitochondria in larval muscle cells (blue) at the indicated time points following illumination and normalized to data obtained at maximum rescue
(15 min for JC-1 and 2 h for mitochondrial morphology). n = 20 muscles or synapses (A, B, E) or 10 brains (C, D). Error bars SEM. ANOVA/Dunnet: ***:
p,0.001.
doi:10.1371/journal.pone.0078562.g003
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consistent with work showing that PBM protects against the loss of
dopaminergic neurons when rodents were intoxicated with the
mitochondrial drug MPTP [27]. Combined, our data provide
further evidence that mitochondria are central to the mechanism
by which PBM yields protective effects. Long wavelength light also
appears to harbor positive effects in wound healing, stroke, optic
axonal degeneration and ischemic heart injury [23–25] and we
speculate that also here improved mitochondrial function may
contribute to the beneficial properties of PBM that are observed.
Providing one explanation as to how PBM acts on cellular
function, we find that near-infrared light stimulates Complex IV-
dependent respiration resulting in increased mitochondrial func-
tion and improved organismal activity. We show that 808 nm light
stimulation was effective in conditions of decreased ETC
performance by either toxic (rotenone) or genetic (pink1) causes
and that it acutely activates Complex IV-dependent oxygen
consumption and ym in pink1 mutant mitochondria. Although in
control animals Complex IV is acutely activated by 808 nm light,
we did not observe an effect on ym and ATP levels, suggesting that
Figure 4. 808 nm light facilitates Complex IV-dependent respiration. A–E- Quantification of the rate of ADP-stimulated oxygen
consumption after versus before light (light green; 808 nm, 100 s, 25 mW/cm2) or mock treatment (dark green) when all substrates were present for
Complex I- (A) or for Complex II- (B) or for Complex IV- (C) driven respiration in mitochondria isolated from control (pink1RV) and pink1B9 mutant flies.
(D, E) Raw data traces showing O2 levels when following Complex IV-driven respiration in control (D) and pink1
B9 (E) mutant mitochondria when light
(light green) or no light (dark green) were applied. F–J- Quantification of the rate of ADP-stimulated oxygen consumption after versus before light
treatment (light green) or mock treatment (dark green) when all substrates were present for Complex I- (F) or for Complex II- (G) or for Complex IV-
(H) driven respiration in mitochondria isolated from wild type (pink1+/+) or pink12/2 knock out mutant mice mitochondria. Raw data traces showing
O2 levels when following Complex IV- driven respiration in pink1
+/+ (I) and pink12/2 mitochondria (J) when light (light green) or no light (dark green)
were applied. n = 3 independent mitochondrial isolations from flies (A–E) and n= three independent trials from 2 mitochondrial isolations from
mouse livers (F–J). Error bars SEM. ANOVA/Dunnet: *: p,0.05; **: p,0.01; ***: p,0.001.
doi:10.1371/journal.pone.0078562.g004
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when sufficient ATP is present, no surplus ATP is being produced.
Our data are also suggesting that Complex IV-driven respiration
may become limiting in the ETC. In Complex I deficient models,
including rotenone treated animals and pink1 mutants, electrons
are still entering the ETC via complex II and inefficiently via
Complex I. Facilitating the downstream Complex IV dependent
respiration that may be limiting appears to be an efficient strategy
to compensate for the genetic or pharmacological defects in
Complex I function. That Complex IV may be more limiting than
Complex I is also illustrated by the severe defects that are caused
by human mutations in Complex IV components in the neonatal
period [37,38].
Our work allows to further elucidate the role of Pink1 in the
regulation of mitochondrial function. Pink1 acts with Parkin to
mediate mitochondrial remodeling and mitophagy [15,17] and
pink1 and parkin fly mutants show an accumulation of large, swollen
mitochondria in some cell types [12,13]. Pink1 mutants also show
enzymatic defects in Complex I of the ETC [7,11,22] but it is
unclear if these phenotypes depend on one another. Based on our
data, we can now assess the dependency and interplay between
these pathways: does light stimulation facilitate mitochondrial
remodeling resulting in improved mitochondrial function or vice
versa?
Our data argue against the possibility where 808 nm light acts
to directly affect mitochondrial remodeling. First, we observe acute
increased mitochondrial oxygen consumption upon 808 nm
illumination of isolated fly and mammalian mitochondria. Second,
mitochondrial fission is a process thought to precede mitophagy;
however, 808 nm light does not alter mitochondrial remodeling in
illuminated control animals and it does not rescue the accumu-
lation of larger mitochondria seen in drp1 loss-of-function mutants.
Third, 808 nm light was also not effective at alleviating the
mitochondrial morphological defects in parkin mutants that suffer
from defects in mitochondrial remodeling and mitophagy. By
contrast, our data supports the notion that 808 nm PBM improves
mitochondrial function and suggest that improved mitochondrial
function is sufficient to, at least in part, rescue the morphological
defects in pink1 mutant mitochondria. In line, the mitochondrial
morphological defects in pink1 mutants were also rescued upon
improving electron transport between NADH and Complex III
using expression of the yeast protein NDI1 [11]. Together, these
data suggest that mitochondrial dysfunction in pink1 mutants is an
important upstream culprit in the pathological cascade that
contributes to different downstream defects, in part including the
morphological defects.
Although 800–850 nm light may fully penetrate a fly brain, in
human this is not likely to occur. To use infrared light as a
therapeutic application in PD patients, implantable devices are
being developed that can irradiate selective regions of the affected
brain-area(s). Since 808 nm light activates Complex IV both in fly
and mammalian mitochondria, our work holds important
therapeutic promise with the ultimate goal to improve mitochon-
drial function in PD patients that suffer from mitochondrial
defects.
Supporting Information
Figure S1 808 nm light only rescues mitochondrial
defects caused by functional defects. A–B- Images (A) and
quantification (B) of JC-1 labeling intensity (ratio of red/green
fluorescence) as a measure of ym, measured at NMJ synaptic
bouton mitochondria of wild type (pink1RV) third instar larvae,
placed as first instar larvae on control food or on food
supplemented with 250 mM rotenone, 5 h after larvae were
illuminated (light stimulation) using 100 s of 808 nm light
(25 mW/cm2) or not illuminated (control) (n = 20 synapses). C–
D- Images of Complex V (anti-ATP synthase b) labeling (C) at
control (y w; FRT40A) and drp11/2 mutant muscles (Muscles 6/7 in
third instar larval) 5 h after animals were illuminated (808 nm,
100 s, 25 mW/cm2) or not illuminated (control). Quantification of
the number of rounded/clumped mitochondria in each condition
(D) (n = 20 muscles). E–I- ATP concentration measured in thoracic
extracts from parkRV control and park1/D21 null mutants 5 h after
flies were illuminated (light stimulation: 808 nm, 100 s, 25 mW/
cm2) or not illuminated (control), normalized to parkRV without
illumination (E). Quantification (F) and images (G) of JC-1 labeling
intensity (ratio of red/green fluorescence) as a measure of ym
measured at NMJ synaptic bouton mitochondria of parkRV control
and park1/D21 null mutant third instar larvae 5 h after animals were
illuminated or not illuminated (n = 20 synapses). Images of
Complex V (anti-ATP synthase b) labeling at parkRV and park1/
D21 mutant muscles (Muscles 6/7 in third instar larval segment A2)
5 h after animals were illuminated or not illuminated (control) (I)
and quantification of the number of rounded/clumped mitochon-
dria in each condition (H) (n = 20 muscles). Data are normalized to
controls without illumination 6 SEM (B, D–F, H). ANOVA/
Dunnet: ***: p,0.001; ns = not significant.
(TIF)
Figure S2 Increased activity of Complex IV leads to
increased ATP production. A- Quantification of the rate of
ADP-stimulated oxygen consumption in the presence of the
Complex IV inhibitor cyanide after light treatment versus before
light stimulation (light green; 808 nm, 100 s, 25 mW/cm2) or after
mock treatment versus before (dark green) in mitochondria
isolated from controls (pink1RV) and pink1B9 mutant flies. n = 3
independent mitochondrial isolations. Error bars SEM. ANOVA/
Dunnet: ns = not significant. B- Time-dependent ATP production
in mitochondria isolated from pink1B9 mutant flies that were 5 h
earlier illuminated (light stimulation: 808 nm, 100 s, 25 mW/cm2)
or not (control). ATP produced in vitro was measured after
15 min and after 30 min, normalized to control stimulation after
15 min. n = 10 assays. C- Quantification of JC-1 labeling intensity
(ratio of red/green fluorescence) as a measure for Ym measured at
NMJ synaptic bouton mitochondria of pink1B9 mutant third instar
larvae 15 min after flies were illuminated (red bars) with different
wavelengths or not illuminated (dark red bar). Dashed line
represents mean values of control (pink1RV) NMJs that were not
illuminated; SEM is indicated in gray (n = 20 synapses per
wavelength and per condition). Error bars SEM. ANOVA/
Dunnett: *: p,0.05; **: p,0.01.
(TIF)
Table S1 Optimization of light stimulus using the flight
capacity of pink1 mutant flies. Values show the flight
percentage 6 SEM with different light conditions and tested at
different time points after the light stimulation.
(TIF)
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